FridayOct 31, 2025 9:20 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Featured in NetworkNewsWire Editorial Highlighting Transition from Explorer to Producer

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “From Explorer to Producer: The Most Compelling Mining Window.” The feature examines how persistent inflation, geopolitical tensions, and constrained supply are driving renewed investor interest in gold and silver producers, with LaFleur positioned as a standout example of a junior miner advancing toward production. Owning a fully permitted and recently refurbished gold-processing mill, LaFleur is years ahead of many peers still pursuing production capabilities, underscoring its intrinsic value…

Continue Reading

FridayOct 31, 2025 9:00 am

QualityStocksNewsBreaks – MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Appoints PTRC President as CEO, Prepares to Drill Canada’s First Deep Natural Hydrogen Well

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced the appointment of Ranjith (Ran) Narayanasamy, current President and CEO of the Petroleum Technology Research Centre (PTRC), as Chief Executive Officer effective Dec. 8, 2025, as it readies to drill Canada’s first-ever deep well specifically targeting Natural Hydrogen within Saskatchewan’s Genesis Trend. The Company is also advancing efforts to unlock the value of its Willcox Playa critical minerals project in southeast Arizona, located adjacent to U.S. Department of Defense lands, with current CEO Mansoor…

Continue Reading

FridayOct 31, 2025 9:00 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Present Sapu003 Data at 2025 San Antonio Breast Cancer Symposium

Oncotelic Therapeutics (OTCQB: OTLC) a biopharmaceutical company advancing transformative cancer therapies through its PDAOAI platform and expertise in nanomedicines, announced that Sapu Nano’s investigational intravenous Deciparticle(TM) everolimus (Sapu003) has been accepted for presentation at the 2025 San Antonio Breast Cancer Symposium, Dec. 9–12, 2025, in San Antonio, Texas. Developed by Sapu Nano, a joint venture between Oncotelic and Dragon Oversea, Sapu003 is a novel Deciparticle(TM) formulation of everolimus designed to improve bioavailability, reduce toxicity, and enhance tumor penetration in HR⁺/HER2⁻ metastatic breast cancer, RCC, and NET. To view the full press release, visit https://ibn.fm/bCNnk About Oncotelic Therapeutics Inc. Oncotelic Therapeutics…

Continue Reading

FridayOct 31, 2025 9:00 am

Nightfood Holdings Inc. (NGTF) Announces $10 Million in Annual Revenue and Expands Pilot Network Ahead of Commercial Rollout

Nightfood Holdings Inc. recently announced that the company is generating approximately $10 million in annual revenue The revenue comes from the company’s diversified portfolio of AI robotics and hospitality assets NGTF also recently announced that the company’s expanding the robotic live pilot programs beyond the hospitality industry Nightfood Holdings (OTCQB: NGTF), dba TechForce Robotics, an AI robotics company, recently announced that it is generating around $10 million in annualized revenue, a result of its diverse portfolio of income-producing hospitality and robotics assets. The company’s acquisition strategy is central to this growth, highlighted by its recent purchase of the 120-room Hilton…

Continue Reading

ThursdayOct 30, 2025 11:35 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Sets Record Loan Volume Following Fed Rate Cut Announcement

Beeline Holdings (NASDAQ: BLNE), the digital mortgage lender built for next-generation homeowners, locked 21 loans totaling nearly $8 million on Oct. 29, the same day the Federal Reserve announced its second consecutive rate cut, marking record highs for the company’s key performance indicators. The Rhode Island-based lender, which declared itself debt-free in September and expects to be cash-flow positive by Q1 2026, credits its AI-driven proprietary platform for its ability to rapidly scale as market conditions improve. To view the full press release, visit https://ibn.fm/lbYxq About Beeline Beeline Holdings, Inc. is a trailblazing mortgage fintech transforming the way people access property…

Continue Reading

ThursdayOct 30, 2025 9:35 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsWire Editorial on Nanomedicine Advances 

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability.” The feature highlights how breakthroughs in nanocarrier-based delivery are reshaping cancer therapy by enhancing efficacy and reducing toxicity. Oncotelic’s proprietary Deciparticle(TM) platform is spotlighted for its potential to improve the bioavailability and therapeutic index of oncology drugs, advancing the broader shift toward precision nanomedicine. To view the full press release, visit https://ibn.fm/HaaEu About Oncotelic Therapeutics Inc. Oncotelic Therapeutics is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The company’s mission is to address high-unmet-need cancers…

Continue Reading

ThursdayOct 30, 2025 9:30 am

QualityStocksNewsBreaks – ECGI Holdings Inc. (OTC: ECGI) Invests in Entrepreneur Media’s Inaugural Venture Capital Fund

ECGI Holdings (OTC: ECGI), a diversified public company advancing its Uplist Ventures strategy, has signed an agreement to invest in Entrepreneur Ventures Fund I, Entrepreneur Media, Inc.’s inaugural venture capital fund. The partnership expands ECGI’s access to institutional-grade deal flow and co-investment opportunities while enhancing its reach among professional investors and venture partners. Entrepreneur Ventures targets early- and growth-stage companies in consumer-facing sectors leveraging Entrepreneur’s network of thousands of founders and investors, representing billions in cumulative venture value. To view the full press release, visit https://ibn.fm/6ONwF About ECGI Holdings ECGI Holdings, Inc. (OTC: ECGI) is a technology-driven investment and development company…

Continue Reading

ThursdayOct 30, 2025 9:00 am

Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) From Humble Beginnings to $18.4 Million Q2 2025 AFFO; Set to Announce Q3 Financial Results on November 6

Strawberry Fields REIT, Inc., a self-administered real estate investment trust, posted its AFFO for Q2 2025 at $18.4 million, up from $14.3 million during the same period in 2024 From 33 Skilled Nursing Facilities (“SNF”) in 2015, the Company has grown its portfolio to 142 healthcare facilities, totaling over 15,500 licensed beds across 10 states in the U.S. Founder, CEO, and Chairman, Moishe Gubin, built Strawberry Fields with an operator point of view, while focusing on the real estate side of things By combining a unique knowledge of the healthcare and real estate industries, the Company positioned itself to carve…

Continue Reading

ThursdayOct 30, 2025 9:00 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present AI Drug Discovery Platforms at Inaugural AI4BM Symposium

Lantern Pharma (NASDAQ: LTRN) will present its commercially deployed AI research platforms, predictBBB.ai and LBx-AI, at the inaugural AI for Biology and Medicine symposium hosted by the University of North Texas. The company will showcase how machine learning is accelerating drug development and precision oncology, including 94.1% accuracy in predicting blood-brain barrier permeability and 86% accuracy in treatment response prediction for non-small cell lung cancer. CEO Panna Sharma said the presentations highlight Lantern’s mission to democratize advanced computational tools and reshape how pharmaceutical companies approach discovery, biomarker development, and CNS-targeted therapeutics. To view the full press release, visit https://ibn.fm/hgxZQ About…

Continue Reading

ThursdayOct 30, 2025 9:00 am

QualityStocksNewsBreaks – D-Wave Quantum to Report Third Quarter Fiscal Year 2025 Financial Results on November 6, 2025

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will release its financial results for the third quarter of fiscal year 2025 ended September 30, 2025 on Thursday, November 6 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavesys.com/. In conjunction with this announcement, D-Wave will host a conference call on Thursday, November 6, 2025, at 8:00 a.m. (Eastern Time), to discuss the Company’s financial results and business outlook. The live dial-in number is 1-844-826-3035 (domestic) or 1-412-317-5195 (international). Participants can use those dial-in numbers or can click this link for instant…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered